Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T37437 |
C17 Ceramide (d18:1/17:0)
|
||
C17 Ceramide is a synthetic ceramide that contains a non-natural C17:0 fatty acid acylated to sphingosine. It has been used as a marker of arylsulfatase A and sphingolipid activator B activity in patients undergoing enzyme replacement therapy for the genetic disease metachromatic leukodystrophy. | |||
T38182 |
C17 Sphingomyelin (d18:1/17:0)
C17 Sphingomyelin (d18:1/17:0) |
||
C17 Sphingomyelin is a synthetic derivative of sphingomyelin that has been used as an internal standard for the quantification of sphingomyelin. | |||
T38181 |
C17 Lactosylceramide (d18:1/17:0)
|
||
C17 Lactosylceramide is a naturally occurring sphingolipid that has been found in human brain metastases of lung adenocarcinomas but not in healthy brain tissue. | |||
T37438 |
C17 Globotriaosylceramide (d18:1/17:0)
C17 Globotriaosylceramide (d18:1/17:0) |
||
C17 Globotriaosylceramide is a sphingolipid that has been used as an internal standard for the quantification of globotriaosylceramides in plasma and urine from patients with Fabry disease by GC-MS. |